text.skipToContent text.skipToNavigation

PAXgene Tissue RNA Kit

For purification of total RNA from tissues fixed and stabilized in PAXgene Tissue Containers
  • Integrated system for fixation, stabilization, and purification
  • High-quality RNA from tissues with preserved morphology

PAXgene Tissue is a new, crosslinking-free, tissue-fixation technology to enable both molecular and traditional pathology testing. It simultaneously stabilizes molecular content and preserves morphology. Tissue samples fixed and stored in PAXgene Tissue Containers can be paraffin-embedded and used for pathology studies as well as for subsequent purification of RNA, miRNA, and/or DNA. The PAXgene Tissue RNA Kit provodes purification of total RNA from tissues fixed and stabilized in PAXgene Tissue Containers. Purification is carried out using silica-based RNA purification technology in a spin-column format. Used with the containers, the kit provides a complete preanalytical solution for collection, fixation, and stabilization through to purification of high-quality RNA for molecular analysis. The procedures can be fully automated on the QIAcube.

Cat No./ID: 765134
PAXgene Tissue RNA Kit (50)
$557.00
Add To Cart
For 50 RNA preps: PAXgene RNA MinElute Spin Columns, PAXgene Shredder Spin Columns, Processing Tubes, Microcentrifuge Tubes, Carrier RNA, RNase-Free DNase, and RNase-Free Buffers; to be used in conjunction with PAXgene Tissue Containers
For Research Use Only. Not for use in diagnostics procedures. No claim or representation is intended to provide information for the diagnosis, prevention, or treatment of a disease.

Specifications for fixation and storage conditions in PAXgene Tissue Fix and PAXgene Tissue Stabilizer were determined using animal tissues.



0
The PAXgene Tissue RNA procedure.
1
RT-PCR of RNA purified from fixed tissue.
Intestine tissue was fixed for 3 hours in PAXgene Tissue Fix, transferred into PAXgene Tissue Stabilizer, and stored for 24 hours. After processing, RNA was purified from sections of paraffin-embedded tissue using the PAXgene Tissue RNA Kit. RT-PCR of amplicons with the given length was carried out using the QIAGEN OneStep RT-PCR Kit. –: No template control. M: markers.
2
High-quality RNA from fixed tissue.

Intestine tissue was fixed for 3 hours in PAXgene Tissue Fix, transferred into PAXgene Tissue Stabilizer, and stored for 24 hours. After processing, RNA was purified from sections of paraffin-embedded tissue using the PAXgene Tissue RNA Kit. Purified RNA was analyzed with an Agilent 2100 Bioanalyzer.

Performance
Total RNA purified using the PAXgene Tissue RNA Kit is of high quality and is highly pure (see figures "High-quality RNA from fixed tissue" and "RT-PCR of RNA purified from fixed tissue"). Genomic DNA contamination is minimized, and purified RNA is ready to use in downstream applications with no detectable PCR inhibition. All RNA molecules longer than 200 nucleotides are purified. The procedure provides enrichment for mRNA since most RNAs <200 nucleotides (such as 5.8S rRNA, 5S rRNA, and tRNAs, which together comprise 15–20% of total RNA) are selectively excluded. The size distribution of the purified RNA is comparable to that obtained by centrifugation on a CsCl gradient, through which small RNAs do not sediment efficiently. For purification of small RNA, including microRNA (miRNA), we recommend using the PAXgene Tissue miRNA Kit.
Principle

Tissue fixation methods used in traditional histology are of limited use for molecular analysis. Fixatives that contain formaldehyde cross-link biomolecules and modify nucleic acids and proteins. During tissue fixation, storage, and processing, cross-links lead to degradation of nucleic acids. Since cross-links cannot be removed completely, the resulting chemical modifications can cause inhibition in sensitive downstream applications such as quantitative PCR or RT-PCR.

The PAXgene Tissue System was developed  to enable both molecular and traditional pathology testing from the same specimen by stabilizing molecular content and preserving morphology. The system consists of a tissue collection device (the PAXgene Tissue Container for collection, stabilization, storage, and transportation of human tissue specimens) and kits for purification of total RNA, DNA, or miRNA. PAXgene Tissue Containers provide tissue fixation for histopathology studies and enable purification of high-quality nucleic acids from the same sample for molecular analysis. The fixation and stabilization method preserves tissue morphology and the integrity of nucleic acids without destructive cross-linking and degradation found in formalin-fixed tissues.

For purification of total RNA, the system requires the use of PAXgene Tissue Containers for tissue collection and stabilization, followed by RNA isolation and purification using the PAXgene Tissue RNA Kit. Together the container and kit provide a complete preanalytical solution for collection, fixation, and stabilization of tissue, and purification of high-quality RNA for molecular analysis.
Procedure

PAXgene Tissue Containers are dual-chamber containers prefilled with 2 reagents. PAXgene Tissue Fix rapidly penetrates and fixes the tissue. After fixation, the tissue is removed from the PAXgene Tissue Fix and transferred to PAXgene Tissue Stabilizer in the second chamber of the same container. When the tissue is stored in PAXgene Tissue Stabilizer, nucleic acids and morphology of the tissue sample are stable from 3 to 7 days at room temperature or from 2 to 4 weeks at 2–8°C, depending on the type of tissue. Storage at –15°C to –30°C is also possible for at least 3 months without any negative effects on the morphology of the tissue or the integrity of the nucleic acids. Stabilized samples can be embedded in paraffin for histological studies. Nucleic acids can be isolated from the stabilized samples either before or after embedding in paraffin. See the PAXgene Tissue Container Product Circular for information about tissue fixation, stabilization, processing, and paraffin embedding.

The PAXgene Tissue RNA Kit provides 3 protocols for purification of total RNA from tissues fixed and stabilized in PAXgene Tissue Containers. Disruption and homogenization of the tissue sample is performed in the binding buffer, Buffer TR1. After a centrifugation step to remove residual cell debris, ethanol is added to the lysate to provide appropriate binding conditions for RNA. The sample is then applied to a PAXgene RNA MinElute spin column, where the total RNA binds to the membrane and contaminants are efficiently washed away. Between the first and second wash steps, the membrane is treated with DNase I to remove trace amounts of bound DNA. After the wash steps, RNA is eluted in a low-salt elution buffer and denatured by heating (see figure "The PAXgene Tissue RNA procedure").

Applications

The purified RNA is ready to use in a wide range of downstream applications, including:

RT-PCR and quantitative, real-time RT-PCR
Expression-array and expression-chip analysis
cDNA synthesis
RNase and S1 nuclease protection
Northern, dot, and slot blot analysis
Primer extension
Features
Specifications
Applications null
Applications null
Elution volume null
Elution volume null
Format null
Format null
Main sample type null
Main sample type null
Processing null
Processing null
Sample amount null
Sample amount null
Technology null
Technology null
Time per run null
Time per run null
Yield null
Yield null

You are not authorized to download the resource

Brochures & Guides (4)
Two worlds in one sample
Show details

Show details
For isolation and purification of intracellular RNA from tissue samples stabilized using the PAXgene Tissue System

 


Show details
Moving toward excellence and standardization in tissue collection and fixation

 


Show details
Kit Handbooks (1)
For isolation and purification of total RNA from tissue samples stabilized in PAXgene Tissue Containers
Show details
Scientific Posters (13)
Hesse et al., AACR-NCI-EORTC 2011

 


Show details
Groelz et al., AACR 2010

 


Show details
Groelz et al., AMP 2008 

 


Show details
Groelz et al., AMP 2009 

 


Show details
Groelz et al., ISBER 2012

 


Show details
Groelz et al., BRN Symposium 2012 

 


Show details
Groelz et al., ECP 2012

 


Show details
Groelz et al., AMP 2009

 


Show details
Groelz et al., 3rd Annual Oncology Biomarkers 2011

 


Show details
Groelz et al., GTEx Meeting 2014

 


Show details
Groelz et al., AMP 2014

 


Show details
Groelz et al., BRN Symposium 2011 

 


Show details
Groelz et al., ECP 2014

 


Show details
References
0
fragment fix placeholder

Customers who bought these products also bought